ELOXX PHARMACEUTICALS, INC. Adjustments to Additional Paid in Capital, Fair Value
ELOXX PHARMACEUTICALS, INC. (ELOX) reported Adjustments to Additional Paid in Capital, Fair Value of $300.00 thousand for the 12-month period ending 2015-12-31, per its 10-K filed 2018-03-16.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalMarkToMarket · last filed 2018-03-16
- ELOXX PHARMACEUTICALS, INC. adjustments to additional paid in capital, fair value for fiscal 2015 was $300.00K.
| Period end | Adjustments to Additional Paid in Capital, Fair Value 12 month |
|---|---|
| 2015-12-31 | $300.00K 10-K · filed 2018-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Tevogen Inc. (TVGN) | United States | $0.049B |